Feasibility of controlling COVID-19

Lancet Glob Health. 2020 Jun;8(6):e774. doi: 10.1016/S2214-109X(20)30129-7. Epub 2020 Apr 30.

Authors

Nian Xiong¹, Zhicheng Lin²

Affiliations

¹ Medical Treatment Expert Group for COVID-19, Wuhan Red Cross Hospital, Wuhan, Hubei, China; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
² McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA. Electronic address: zhicheng_lin@hms.harvard.edu.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections*
Feasibility Studies
Humans
Pandemics
Pneumonia, Viral
SARS-CoV-2